alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED, SUCH SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
COVERING SUCH SECURITIES UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE
COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.
 Warrant No. W  4
    
    Number of Shares  7,500Date of Issuance: July 22, 2009
    
    (subject to adjustment)
 WARRANT TO PURCHASE
COMMON STOCK OF
CUMBERLAND PHARMACEUTICALS, INC.
(Void after July 22, 2019)
 Warrant Company Bank Holder
 AGREEMENT:
 Line of Credit Term Loan Line of Credit Loans Line of Credit Note Term Note Notes Loan Agreement Exercise
Price Common
Stock




---



##### 



Expiration Date Exhibit A, Section 3
  1. Exercise; Issuance of Certificates; Payment for Shares.
 1.1 General.
 1.2 Net Issue Exercise.
 X =
    Y (A-B)A
  -2-




---



##### 



Determination Determination Notice . Valuer
  2. Shares to be Fully Paid; Reservation of Shares.
 -3-




---



##### 



provided, however, Section 3
 3. Adjustment of Exercise Price and Number of Shares. Section 3.
 3.1 Subdivision or Combination of Stock.
 3.2 Dividends in Common Stock Other Stock, Property, Reclassification.
 (a)
 (b)
 (c)
 -4-




---



##### 



Section 3.1 clause (b) clause (c))
 3.3 Reorganization, Reclassification, Consolidation Merger or Sale. Organic Change
 3.4 Certain Events. Section 3
 -5-




---



##### 



4. Issue Tax. r provided, however,
 5. Closing of Books.
 6. No Voting or Dividend Rights; Limitation of Liability. Section 3.2
 7. Rights and Obligations Survive Exercise of Warrant.
 8. Amendments.
 (a) Section 8
 (b)
 9. Notices.
 (a) Section 3
 
 -6-




---



##### 



(b)
 (i)
 (ii)
 (iii)
  (c)
 11. Binding Effect on Successors.
 -7-




---



##### 



Exhibit B,
 12. Descriptive Headings.
 13. Governing Law.
 14. Replacement Warrants.
 15. Fractional Shares,
 16. Equity Participation.
 17. No Novation
 (The balance of this page is intentionally left blank.]
 -8-




---



##### 



IN WITNESS WHEREOF
 CUMBERLAND PHARMACEUTICALS, INC.By:
    /s/ David L. LowranceName:
    David L. LowranceTitle:
    CFO




---



##### 



EXHIBIT A
 NOTICE OF EXERCISE
  o
 o  Section 1.2
  (Name)(Name)
  (Name)(Name)(Signature)(Date)




---



##### 



EXHIBIT B
 ASSIGNMENT FORM
  Name of Assignee
    
    Address
    
    No. of Shares
 (Date)
    
    (Signature)
Exhibit 10.1 

TERMINATION OF JOINT VENTURE AGREEMENT

WHEREAS, on January 10, 2011, LIFECYCLE INVESTMENTS, L.L.C., an Illinois limited liability company (“LCI”) and GLOBAL EARTH ENERGY INC., a Nevada corporation (“GLER”) executed that certain Joint Venture Agreement (the “Joint Venture Agreement”) with respect to the recapitalization of life settlements relating to certain life settlements owned by LifeCycle and lien holder First Chicago Bank and Trust, and the split of proceeds from the death benefits between the parties; and

WHEREAS, LCI and GLER desire to terminate the Joint Venture Agreement;

NOW, THEREFORE, in consideration of the foregoing and the following mutual covenants and agreements, the parties do hereby agree as follows:

Termination of the Joint Venture Agreement.  Effective as of the date hereof, LCI and GLER do hereby terminate the Joint Venture Agreement.  LCI and GLER do further agree that neither party shall have any further obligation or liability in connection with the Joint Venture Agreement.

IN WITNESS WHEREOF, the parties have executed this Termination of Joint Venture Agreement as of November 8, 2011.

LIFECYCLE INVESTMENTS, L.L.C.







By: /s/ Andrew Madenberg

 Andrew Madenberg, Chief Executive Officer







GLOBAL EARTH ENERGY, INC.







By /s/ Sydney A. Harland

Sydney A. Harland, Chief Executive Officer
<PAGE>
                                                                    EXHIBIT 99.1
                                 CERTIFICATION

     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, James M.
McCluney, Chief Executive Officer of Vixel Corporation (the "Company"), and
Kurtis L. Adams, the Chief Financial Officer of the Company, each hereby
certify that, to the best of his knowledge:

1. The Company's Annual Report on Form 10-K/A for the period ended December 29,
2002, and to which this Certification is attached as Exhibit 99.1 (the
"PERIODIC REPORT") fully complies with the requirements of section 13(a) or
section 15(d) of the Securities Exchange Act of 1934, and

2. The information contained in the Periodic Report fairly presents, in all
material respects, the financial condition of the Company as of December 29,
2002 and the results of its operations for the period covered by the Periodic
Report.

     IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the
1st day of July, 2003.


                                                /s/ James M. McCluney
                                      ------------------------------------------
                                      JAMES M. MCCLUNEY, CHIEF EXECUTIVE OFFICER

                                                /s/ Kurtis L. Adams
                                      ------------------------------------------
                                      KURTIS L. ADAMS, CHIEF FINANCIAL OFFICER
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2957 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2957

       To suspend temporarily the duty on certain coupon holders.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 8, 2012

 Ms. Klobuchar introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
       To suspend temporarily the duty on certain coupon holders.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN COUPON HOLDERS.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Divided pouches of  Free         No change        No change        On or before 12/  ''.
                        plastic sheeting,                                                  31/2015.......
                        each with a flap
                        closure secured
                        by a snap, magnet
                        or elastic band
                        and hook, the
                        foregoing not
                        exceeding 203.2
                        mm in height,
                        width or depth
                        and of a type
                        designed for
                        organizing
                        coupons or other
                        printed matter
                        (provided for in
                        subheading
                        4202.32.20)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
**Exhibit 23.1**

 

**Consent of Independent Registered Public AccountingFirm**

 

We consent to the inclusionof our report dated March 15, 2005 (except for Note 2, as to which the date isNovember 15, 2005) with respect to the consolidated financial statementsof Tri-S Security Corporation included in their Annual Report Amendment No. 1 onForm 10-K/A for the year ended December 31, 2004 as well as theincorporation by reference of such report in the Company’s previously filedRegistration Statements File No. 333-119737 and File No. 333-129097.

 
| /s/  Miller Ray Houser & Stewart LLP |   |
|-----------------------------------------------|--------|

 

Atlanta, GeorgiaNovember 15, 2005

 

----
**Exhibit 32.2**

**Certification ofQuarterly Report**

I, Caroline M.Loewy, Chief Financial Officer of Poniard Pharmaceuticals, Inc. (the “Company”),certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18U.S.C. 1350 that:

a.                 the QuarterlyReport on Form 10-Q for the quarter ended March 31, 2007 (the “Report”)fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

b.                theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.
| Date: May 10, 2007 |   | By:    |   | /s/ CAROLINE M. LOEWY |
|-------------------------|--------|--------|--------|-----------------------|
|                    |   |   |   | Caroline M. Loewy     |

 

----
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2826 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2826

            To extend the suspension of duty on Basic Red 1.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Kerry introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
            To extend the suspension of duty on Basic Red 1.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BASIC RED 1.

    (a) In General.--Heading 9902.22.22 of the Harmonized Tariff 
Schedule of the United States (relating to Basic Red 1) is amended by 
striking the date in the effective period column and inserting ``12/31/
2015''.
    (b) Effective Date.--The amendment made by this section applies to 
goods entered, or withdrawn from warehouse for consumption, on or after 
the 15th day after the date of the enactment of this Act.
                                 <all>
```
Nanosys

Worker Activity EPA Sanitized

Task

Worker Activity Personal Protective Equipment/Eng

Controls Phy Forms and % product # Workers

Exposed

Max

(hrs/day)

Duration

(days/yr)

C1

QD Matrix with Aminosilicone is applied using a

dispensing system that mixes the QD Matrix with

Aminosilicone with Epoxy Part A and Part B. The mixture

is dispensed in‐between two plastic films and allowed to

cure. The resulting product is a QD Efficiency Film

(QDEF).

Dispensing system, closed bottle,

nitrile gloves, safety glasses, lab coat.

Liquid from bottles is mixed in a

dispenser with Part A and Part B

Epoxies and applied in between two

sheets of plastic

2 2.00 255

Customer ‐ QD Efficiency Film (QDEF)

PMN Page 9 Attachment

Section A--(2) Occupational Exposure 

Page 1 of 1
EXHIBIT 31.1
SECTION 302 CERTIFICATION
OF CHIEF EXECUTIVE OFFICER

I, George Tsafalas, Chief Executive Officer of Fairchild International Corporation, certify that:

1.	I have reviewed this Quarterly Report on Form 10-QSB of Fairchild International Corporation;

2.	Based on my knowledge, this  report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

1. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
2. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
3. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the small business issuer's most recent fiscal quarter (the small business issuer's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the small business issuer's internal control over financial reporting; and

1. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

1. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
2. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 15, 2004

/s/ George Tsafalas

_____________________________
George Tsafalas, President
and Chief Executive Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2707 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2707

    To extend the temporary suspension of duty on Levapren-Levamel.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Casey introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
    To extend the temporary suspension of duty on Levapren-Levamel.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LEVAPREN-LEVAMEL.

    (a) In General.--Heading 9902.24.55 of the Harmonized Tariff 
Schedule of the United States (relating to certain ethylene-vinyl 
acetate copolymers) is amended by striking the date in the effective 
period column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
[Federal Register Volume 74, Number 74 (Monday, April 20, 2009)]
[Notices]
[Page 17993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-8932]


-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Employment and Training Administration

[TA-W-65,458]


Diversified Machine, Inc., Milwaukee, WI; Notice of Termination 
of Investigation

    Pursuant to Section 221 of the Trade Act of 1974, as amended, an 
investigation was initiated on March 3, 2009 in response to a petition 
filed by a company official on behalf of workers at Diversified 
Machine, Inc., Milwaukee, Wisconsin.
    The petitioner has requested that the petition be withdrawn. 
Consequently, the investigation has been terminated.

    Signed at Washington, DC, this 26th day of March 2009.
Richard Church,
Certifying Officer, Division of Trade Adjustment Assistance.
[FR Doc. E9-8932 Filed 4-17-09; 8:45 am]
BILLING CODE 4510-FN-P
II 

112TH CONGRESS 

2D SESSION S. 3069 

To reduce temporarily the duty on certain sports footwear valued over $6.50 

but not over $12/pair. 

IN THE SENATE OF THE UNITED STATES 

MAY 9, 2012 

Mr. WYDEN introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To reduce temporarily the duty on certain sports footwear 

valued over $6.50 but not over $12/pair. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. CERTAIN SPORTS FOOTWEAR VALUED OVER 

4 $6.50 BUT NOT OVER $12/PAIR. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 


ebenthall on DSK5SPTVN1PROD with BILLS
2 

•S 3069 IS

‘‘ 9902.01.00 Sports footwear with outer 

soles and uppers of rubber or 

plastics, valued over $6.50 

but not over $12/pair, the 

foregoing not for men (provided for in subheading 

6402.19.70) ........................... 47¢/pr. 

+ 

10.5% No change No change On or before 

12/31/2015 ’’. 

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies with respect to goods entered, or 

3 withdrawn from warehouse for consumption, on or after 

4 the 15th day after the date of the enactment of this Act. 

Æ 


ebenthall on DSK5SPTVN1PROD with BILLS
**EXHIBIT
      32.1**




STATEMENT
      REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT


TO
      SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Quarterly Report on Form 10-QSB of GFR Pharmaceuticals,
      Inc.
      (the "Company") for the three and six months ended June 30, 2007, as filed
      with
      the Securities and Exchange Commission on the date hereof (the "Report"), I,
      Su,
      Jie, Chief Executive Officer of the Company, certify that:





*   the
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




*   information
      contained in the Report fairly presents, in all material respects, the financial
      condition and results of operations of the Company.







/s/
      Su, Jie


Su,
      Jie


Chief
      Executive Officer








August
      15, 2007







This
      certification accompanies this Report pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by
      the
      Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of
      Section 18 of the Securities Exchange Act of 1934, as amended.
Exhibit 32.2

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Energy Quest Inc. (the Company) on Form 10-Q for the period ended March 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Vasant K. Jain, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002that:

|1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and                               
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------
|  
|2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|Date: May 15, 2008 | By:/s/ Vasant K. Jain            
|------------------ | ---------------------------------
|                   | Vasant K. Jain                   
|                   | Director, Chief Financial Officer

---
# £5 1 UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 

REGION 5 

77 WEST JACKSO N BOULEVAR D 

CHICAGO, IL 60604-3590 

m ? 3 2 '013 REPLY TO THE ATTENTION OF: 

NOTICE OF PUBLIC COMMENT PERIOD EXTENSION 

FOR 

THE PROPOSED MODIFICATION OF VEOLIA'S TITLE V PERMIT 

This notice is to inform all interested members of the public that the U.S. Environmental 

Protection Agency is extending the time to comment on the proposed modification of the Clean 

Air Act Title V operating permit for Veolia ES Technical Solutions, L.L.C. (Veolia). Veolia is 

located at 7 Mobile Avenue, Sauget, St. Clair County, Illinois. The public comment period was 

originally scheduled to close on March 15, 2013. The public comment period will now close at 

midnight on April 1, 2013. EPA will consider all relevant comments received by EPA on or 

before April 1, 2013 in making a final decision in this matter. 

Members ofthe public may review the administrative record for the modifications contained in 

the draft permit, including copies of the draft permit prepared by EPA, the statement of basis for 

the draft permit, the application, information on how to file comments, and all data and 

supporting materials submitted by the applicant at the following locations: 

(1) www.regulations.gov docket ID EPA-R05-OAR-2012-0649; 

(2) www.epa.gov/region5/newsevents/ and look in the "public comment" section; 

(3) Central Library, 1301 Olive St., St. Louis, MO 63101; 

(4) East St Louis Library, 5300 State St., East St. Louis, IL 62203; 

(5) Cahokia Public Library, 140 Cahokia Park Drive, East St. Louis, IL 62206; and 

(6) EPA Region 5, 77 West Jackson Boulevard, 18th floor, Chicago, Illinois 60604, by 

contacting David Ogulei at (312) 353-0987 or ogulei.david@epa.gov. 

This notice does not apply to any other proceedings related to this matter, including the public 

hearing which is scheduled for February 19, 2013. The public hearing will be held as scheduled. 

Recycled/Recyclable • Printed with Vegetable Oil Based Inks on 100% Recycled Paper (100% Post-Consumer)
Exhibit 32.2

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Rebecque J. Laba, Vice President, Finance and Administration of Celladon Corporation (the Registrant), do hereby certify in accordance with 18
U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based upon my knowledge:



|(1) | this Annual Report on Form 10-K of the Registrant, to which this certification is attached as an exhibit (the Report), fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (15 U.S.C. 78m); and
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------

Date: March 31, 2014



/s/ Rebecque J. LabaRebecque J. LabaVice President, Finance and Administration


The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as
part of the Report or as a separate disclosure document.